All data are based on the daily closing price as of March 28, 2025
z

Zeria Pharmaceutical

4559.TSE
15.38 USD
-0.18
-1.16%

Overview

Last close
15.38 usd
Market cap
678.10M usd
52 week high
16.10 usd
52 week low
12.18 usd
Target price
21.16 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.2362
Price/Book Value
1.2002
Enterprise Value
812.33M usd
EV/Revenue
1.4738
EV/EBITDA
11.9134

Key financials

Revenue TTM
543.78M usd
Gross Profit TTM
281.32M usd
EBITDA TTM
124.52M usd
Earnings per Share
1.27 usd
Dividend
0.31 usd
Total assets
1.00B usd
Net debt
125.49M usd

About

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; and proton pump inhibitors. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.
  • Symbol
    4559.TSE
  • Exchange
    TSE
  • Isin
    JP3428850006
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Sachiaki Ibe
  • Headquarter
    Tokyo
  • Web site
    https://www.zeria.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top